
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.540 | 7.540 | 0.000 |
Shares | 92.850 | 93.210 | 0.360 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.043 | 19.904 |
Price to Book | 3.447 | 3.071 |
Price to Sales | 3.422 | 2.636 |
Price to Cash Flow | 11.063 | 11.739 |
Dividend Yield | 0.996 | 2.208 |
5 Years Earnings Growth | 3.999 | 10.130 |
Number of long holdings: 263
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 9.90 | 118.21 | +0.88% | |
Amgen | US0311621009 | 8.16 | 292.40 | +0.78% | |
Vertex | US92532F1003 | 7.86 | 407.37 | -0.10% | |
Regeneron Pharma | US75886F1075 | 5.42 | 557.73 | -1.22% | |
Alnylam | US02043Q1076 | 4.02 | 464.95 | +0.98% | |
AstraZeneca ADR | US0463531089 | 3.89 | 84.51 | -0.02% | |
Biogen | US09062X1037 | 1.75 | 144.69 | -1.28% | |
Insmed | US4576693075 | 1.72 | 163.94 | +0.99% | |
argenx ADR | US04016X1019 | 1.70 | 799.56 | +0.33% | |
ProShares Ultra Nasdaq Biotechnology | US74347R2141 | 1.68 | 64.38 | +0.86% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDII USD | 2.17B | 15.54 | 28.97 | 18.24 | ||
GF Global Selction Eq QDII USD | 1.36B | 18.19 | 31.45 | 13.66 | ||
GF American Estate Index QDII USD | 21.47M | 2.03 | 7.80 | 4.32 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review